It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Aims
Heart failure with reduced ejection fraction (HFrEF) significantly impacts health‐related quality of life (HR‐QoL). Existing HR‐QoL questionnaires can show inconsistencies, potentially misrepresenting patient self‐reports. This study examines the variation in HR‐QoL measurement tools for HFrEF patients, identifying related determinants.
Methods and results
We retrospectively analysed 134 hospitalized patients with acute decompensated HFrEF at a Taiwanese tertiary centre's Heart Failure Post‐Acute‐Care (HF‐PAC) programme. Participants completed the EuroQol‐5 dimension (EQ‐5D) questionnaire, the EQ‐5D visual analogue scale (VAS), and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Utility values were obtained from the EQ‐5D questionnaire. Demographic features were depicted using descriptive statistics, while multivariate regression was used to ascertain relationships between HR‐QoL measurements and determinants. Average scores for EQ‐5D, MLHFQ, EQ‐5D utility, and VAS were 6.1 ± 1.6, 21.8 ± 21.3, 81.7 ± 27.0, and 59.5 ± 14.6, respectively. Significant correlations were observed among the three tools. The New York Heart Association functional class showed a notable association with all tool scores. Other associations encompassed EQ‐5D with coronary artery disease, mineralocorticoid receptor antagonists, and the 6 min walk test; EQ‐5D VAS with chronic kidney disease; and MLHFQ with age.
Conclusions
This study illuminates the variance in HR‐QoL measurement tools for Taiwanese HFrEF patients. Using a range of these tools is beneficial in unveiling diverse determinants and approaching comprehensive patient‐centred care. However, for a more precise HR‐QoL assessment in Taiwanese HFrEF patients, recalibrating the EQ‐5D‐derived utility scores might be necessary, emphasizing the importance of patient‐specific considerations within the HF‐PAC programme.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Kuo, Fang‐Hsiu 3 ; Toh, Han Siong 4 ; Yang, I‐Ning 5 ; Chang, Wei‐Ting 3 ; Lee, Mei‐Chuan 6 ; Chung, Kai‐Ning 3 ; Huang, Chi‐Ya 7 ; Hsu, Wan‐Hsuan 8 ; Chang, Ting‐Chia 9 ; Shih, Jhih‐Yuan 10 ; Liao, Chia‐Te 11 1 Baroda Medical College, Vadodara, India, World Youth Heart Federation, Vadodara, India
2 Department of Nursing, Chang Gung University of Science and Technology, Chronic Diseases and Health Promotion Research Center, Chiayi, Taiwan
3 Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
4 Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan, Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan
5 Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan
6 Department of Pharmacy, Chi Mei Medical Center, Tainan, Taiwan, Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
7 Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
8 Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
9 Division of Chest Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
10 Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan, Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan
11 Division of Cardiovascular Medicine, Chi Mei Medical Center, School of Medicine, College of Medicine, National Sun Yat‐sen University, Kaohsiung, Taiwan





